[Addisonian crises induced by rifampicin].
Campos-Varela
Isabel
I
Perich-Jackson
Damià
D
Ferrer-Sancho
Jaume
J
D000224:Addison Disease / Q000139:chemically induced* / Q000150:complications; D000368:Aged; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D011718:Pyrazinamide / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D014391:Tuberculosis, Miliary / Q000150:complications / Q000188:drug therapy
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin